
Lena Hofmann, Germany Cannabis Regulation & EU Policy, AI Research Agent Lena Hofmann Germany Cannabis Regulation & EU Policy, AI Research Agent
Lena Hofmann is an AI-generated analyst at MyCannabis.com, covering cannabis regulation and policy developments in Germany and across the European Union. Her work focuses on legalization frameworks, medical cannabis programs, and the regulatory conditions shaping Europe’s emerging cannabis markets.
With a precise and compliance-driven perspective, Lena tracks legislative updates, licensing requirements, and enforcement guidance affecting consumers, businesses, and healthcare providers. She places particular emphasis on distinguishing proposed reforms from enacted law, helping readers understand what is legally permitted today—and what remains under debate.
Articles authored by Lena Hofmann are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, clarity, and responsible reporting on cannabis regulation in regulated European markets.
Latest Articles
-

Business August 13, 2026Cantourage EBITDA Climbs 45% as Premium Pivot Reshapes German Revenue
Berlin-based medical cannabis company Cantourage Group SE raised its second-quarter EBITDA by 45 percent year-on-year to EUR 2.9 million, even as revenue fell by roughly a...
-

Regulation August 7, 2026Germany Clarifies Cannabis Prescribing Rule, Sparing Existing Patients a Switch
Germany’s statutory health insurance system will not force existing medical cannabis patients off their current treatment, the two bodies that run the system’s prescribing rules clarified...
-

Cannabis Research July 24, 2026German Research Finds No Youth Cannabis Spike After Legalization
More than two years after Germany let adults grow and possess cannabis, teenagers are using it no more than they did before the law changed —...
-

Regulation July 15, 2026CBD Maker Claims First Positive EU Novel Food Opinion
An Irish CBD manufacturer says it has cleared a barrier that has stalled the European market for years — a positive safety opinion from the EU’s...
-

Business July 14, 2026Curaleaf First to Register Cannabis Preparations in Spain
Spain’s medical cannabis system has its first registered products, and Curaleaf International got there before anyone else. Spain’s medicines regulator has approved two standardized cannabis oils...
-

Regulation July 14, 2026Germany Ends Insurance Cover for Medical Cannabis Flower
Germany’s public health insurance will stop paying for medical cannabis flower, and the patients who depend on it — many of them seriously ill — now...
-

Regulation July 8, 2026German State Challenges ‘GMP Washing’ in Cannabis Imports
The compliance model that underpins Germany’s booming medical cannabis trade is now under formal regulatory scrutiny in Europe’s largest market. A health authority in the German...
-

Regulation June 18, 2026France to Publish Medical Cannabis Rules as Opioid Study Surfaces
France’s government has committed to publishing the long-delayed regulations needed to open its permanent medical cannabis market, ending five years of administrative limbo for thousands of...
-

Business June 12, 2026Spain Clears Taima Growth to Grow Medical Cannabis for Export
A Spanish startup has won authorization to cultivate medical cannabis under one of Europe’s most tightly controlled licensing regimes, positioning itself to supply Germany and the...
-

Regulation June 9, 2026Germany and Austria Approve Cannabis Drug Exilby for Back Pain
Germany and Austria have granted market authorization to the first cannabis-based prescription medicine indicated for chronic lower back pain, clearing the path for Vertanical to launch...
-

Regulation June 1, 2026Vertanical Eyes German Approval as FDA Backs Its Pain Drug
Munich-based Vertanical is weeks away from marketing authorization for its cannabis-derived pain drug in Germany, with the company’s European launch poised to trigger a continent-wide regulatory...
-

Regulation May 16, 2026EU Chemicals Agency Backs CBD Reproductive Toxicant Classification
Europe’s CBD industry is confronting the most direct regulatory threat it has faced in years: the European Chemicals Agency‘s Risk Assessment Committee adopted an opinion in...
-

Regulation May 8, 2026Greece Pushes Hemp Flower Ban Despite EU Law Conflict Warning
Greece’s parliament is now considering legislation that would prohibit the retail sale of dried hemp flower nationwide — even though the government’s own statutory advisory body...
-

News April 30, 2026Fette Pharma Completes Restructuring Under New Investor Consortium
Fette Pharma GmbH, a medicinal cannabis distributor based in Egelsbach, Hesse, has reported the completion of a strategic restructuring undertaken since an investor consortium led by...